These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35323085)

  • 1. Single-administered GnRH agonist as luteal phase support in insemination cycles: a randomized controlled trial.
    Leppänen R; Tinkanen H; Huhtala H; Ahinko K
    Gynecol Endocrinol; 2022 May; 38(5):438-442. PubMed ID: 35323085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.
    Fusi FM; Brigante CM; Zanga L; Mignini Renzini M; Bosisio C; Fadini R
    Reprod Biol Endocrinol; 2019 Nov; 17(1):103. PubMed ID: 31783862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial.
    Bellver J; Labarta E; Bosch E; Melo MA; Vidal C; RemohĂ­ J; Pellicer A
    Fertil Steril; 2010 Aug; 94(3):1065-71. PubMed ID: 19501354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.
    Oliveira JB; Baruffi R; Petersen CG; Mauri AL; Cavagna M; Franco JG
    Reprod Biol Endocrinol; 2010 Sep; 8():107. PubMed ID: 20825643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live birth associated with peak serum estradiol levels in letrozole intrauterine insemination cycles.
    New EP; Kodama S; Devine K; Jahandideh S; Imudia AN; Plosker SM
    Fertil Steril; 2023 May; 119(5):785-791. PubMed ID: 36634734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of gonadotrophin-releasing hormone agonist therapy to improve the outcomes of intrauterine insemination in patients suffering from stage I-II endometriosis.
    Zhang K; Huang S; Xu H; Zhang J; Wang E; Li Y; Zhu C; Shu J
    Ann Med; 2022 Dec; 54(1):1330-1338. PubMed ID: 35535701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal phase support with progesterone does not improve pregnancy rates in patients undergoing ovarian stimulation with letrozole.
    Dilday E; Gigg M; Hoyos L; Quinn M; Markovic D; Kroener L
    Reprod Biomed Online; 2023 Jan; 46(1):123-128. PubMed ID: 36396533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary block with gonadotrophin-releasing hormone antagonist during intrauterine insemination cycles: a systematic review and meta-analysis of randomised controlled trials.
    Vitagliano A; Saccone G; Noventa M; Borini A; Coccia ME; Nardelli GB; Saccardi C; Bifulco G; Litta PS; Andrisani A
    BJOG; 2019 Jan; 126(2):167-175. PubMed ID: 29862633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
    Ata B; Yakin K; Balaban B; Urman B
    Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does multifollicular development and number of intermediate follicles contribute to the effect of luteal phase support with vaginal progesterone gel in intrauterine insemination cycles?
    Tokgoz VY; Sipahi M; Aydin Y; Tekin AB
    Gynecol Endocrinol; 2020 Jan; 36(1):72-76. PubMed ID: 31237153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin Releasing Hormone Agonist Final Oocyte Maturation and Human Chorionic Gonadotropin as Exclusive Luteal Support in Normal Responders.
    Beck-Fruchter R; Baram S; Geslevich Y; Weiss A
    Gynecol Obstet Invest; 2019; 84(1):27-34. PubMed ID: 30048969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
    Erdem A; Erdem M; Atmaca S; Guler I
    Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of ovarian stimulation on the outcome of intrauterine insemination treatment: an analysis of 8893 cycles.
    Liu J; Li TC; Wang J; Wang W; Hou Z; Liu J
    BJOG; 2016 Sep; 123 Suppl 3():70-5. PubMed ID: 27627603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of single dose GnRH agonist to luteal phase support in artificial cycle frozen embryo transfer: a randomized clinical trial.
    Ye H; Luo X; Pei L; Li F; Li C; Chen Y; Zhang X; Huang G
    Gynecol Endocrinol; 2019 Jul; 35(7):618-622. PubMed ID: 30700175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-luteal phase gonadotropin-releasing hormone agonist support in frozen-thawed embryo transfers during artificial cycles: A prospective interventional pilot study.
    Seikkula J; Ahinko K; Polo-Kantola P; Anttila L; Hurme S; Tinkanen H; Jokimaa V
    J Gynecol Obstet Hum Reprod; 2018 Oct; 47(8):391-395. PubMed ID: 29684629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.